Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Price:
20.68
USD
-0.39%
Market Closed
Market Cap:
$3.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
Acanthe Developpement SE
F:ADX
|
FR |
|
Plenti Group Ltd
ASX:PLT
|
AU |
|
CareDx Inc
NASDAQ:CDNA
|
US |
|
Japan Hotel Reit Investment Corp
OTC:NIPOF
|
JP |
|
J
|
Japan Real Estate Investment Corp
F:JUA
|
JP |
|
Arista Networks Inc
NYSE:ANET
|
US |
|
Ansal Properties and Infrastructure Ltd
NSE:ANSALAPI
|
IN |
|
Change Financial Ltd
OTC:CNGFF
|
AU |
|
Pioneer Credit Ltd
ASX:PNC
|
AU |
|
Repsol SA
MAD:REP
|
ES |
|
APC Minerals Ltd
ASX:APC
|
AU |
|
T
|
Transocean Ltd
DUS:TOJ
|
CH |
|
Central Pattana PCL
SET:CPN
|
TH |
|
Autoneum Holding AG
F:AN9
|
CH |
|
V
|
Vingroup JSC
VN:VIC
|
VN |
|
Equasens SA
PAR:EQS
|
FR |
|
R
|
Ryder System Inc
F:RYD
|
US |
|
P
|
Petra Diamonds Ltd
SWB:FPO
|
UK |
|
M
|
Mondi PLC
F:KYC1
|
UK |
|
E
|
Eventbrite Inc
SWB:EB4
|
US |
|
Lake Winn Resources Corp
F:EE1
|
CA |
|
Bank of The James Financial Group, Inc
NASDAQ:BOTJ
|
US |
|
C
|
Compass Inc
NYSE:COMP
|
US |
Wall St Price Targets
ACAD Price Forecast
Based on 22 analysts
Based on 22 analysts
+57% Upside
from
$20.68
today
ACADIA Pharmaceuticals Inc (ACAD)’s 12-month stock price forecast through October 2027 has a consensus target of $32.56, implying 57% upside. The forecast is based on price targets from 22 Wall Street analysts.
ACAD Analyst Rating
Based on 20 analysts
Based on 20 analysts
Analysts rate ACAD Buy, with 14 of 20 recommending Buy or Strong buy.
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACAD's stock price target?
Price Target
32.56
USD
32.56
USD
According to Wall Street analysts, the average 1-year price target for ACAD is 32.56 USD with a low forecast of 16.16 USD and a high forecast of 38.85 USD.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.